TB-Related Stigma: A Hidden Obstacle to Adherence Monitoring with Video Directly Observed Treatment Among Patients with Tuberculosis in Uganda
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Tuberculosis patients experiencing anticipated stigma missed more video directly observed treatment (VDOT) submissions. Addressing stigma is crucial for improving VDOT adherence and patient engagement in TB treatment.
Area Of Science
- Public Health
- Infectious Diseases
- Mental Health
Background
- Video directly observed treatment (VDOT) adherence is inconsistent, with stigma potentially impacting patient engagement.
- Tuberculosis (TB) stigma may lead to missed VDOT submissions, affecting treatment monitoring.
- This study investigated the link between TB-related stigma and missed VDOT submissions.
Purpose Of The Study
- To examine the association between baseline TB-related stigma and missed VDOT submissions.
- To identify specific types of stigma (self, anticipated, public) that affect VDOT adherence.
- To understand the impact of stigma on patient engagement in TB treatment.
Main Methods
- Secondary analysis of 71 TB patients from the DOT Selfie RCT in Kampala, Uganda.
- Measured baseline TB-related stigma using a 13-item tool (self, anticipated, public stigma).
- Used negative binomial regression to analyze the association between stigma and missed VDOT submissions, adjusting for covariates.
Main Results
- High overall stigma (51%) and anticipated stigma (68%) were prevalent.
- High overall stigma increased missed VDOT submissions (aIRR=1.9).
- Anticipated stigma doubled the rate of missed VDOT videos (aIRR=2.1); self and public stigma showed no significant association.
Conclusions
- TB-related stigma, especially anticipated stigma, negatively impacts VDOT adherence.
- Interventions like early stigma screening, counseling, and community education are vital.
- Addressing stigma can improve VDOT adherence and TB treatment outcomes.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
• Class zero: The individual has no known TB exposure and has a negative tuberculin skin test.
• Class one: The individual has been exposed to...